Esprinet SpA (MIL:PRT) 1-Year Sharpe Ratio: 1.30 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:PRT Esprinet SpA MIL:PRT
69 GF Score
Price €7.03
GF Value €5.80
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Esprinet SpA 1-Year Sharpe Ratio?

Esprinet SpA MIL:PRT -1.40% 69 1-Year Sharpe Ratio is 1.30 as of Jul. 17, 2026. GuruFocus rates MIL:PRT with a GF Score™ of 69/100 and a GF Value™ of €5.80 (Modestly Overvalued). The stock has 9 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-17), Esprinet SpA's 1-Year Sharpe Ratio is 1.30.

Esprinet SpA  (MIL:PRT) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Esprinet SpA 1-Year Sharpe Ratio Related Terms

MIL:PRT vs SNX, ARW, AVT: 1-Year Sharpe Ratio Comparison

For the Electronics & Computer Distribution subindustry, Esprinet SpA's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Esprinet SpA 1-Year Sharpe Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Esprinet SpA's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Esprinet SpA's 1-Year Sharpe Ratio falls into.


MIL:PRT
69GF Score
Esprinet SpA MIL:PRT
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Esprinet SpA 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 1.30 mean?
Esprinet SpA (MIL:PRT) has a 1-Year Sharpe Ratio of 1.30 as of Jul. 17, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Esprinet SpA and its competitors.
Is Esprinet SpA's 1-Year Sharpe Ratio too high?
Esprinet SpA's current 1-Year Sharpe Ratio is 1.30. Overall, Esprinet SpA has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Esprinet SpA's 1-Year Sharpe Ratio compare to SNX and ARW?
Esprinet SpA's 1-Year Sharpe Ratio of 1.30 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Hardware company?
A good 1-Year Sharpe Ratio depends on the Hardware industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Esprinet SpA and its competitors. Esprinet SpA's current 1-Year Sharpe Ratio is 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Esprinet SpA stock overvalued right now?
Based on GuruFocus' analysis, Esprinet SpA (MIL:PRT) is currently considered Modestly Overvalued. The stock's GF Value™ is €5.80, compared to a current price of €7.03 — trading 21.2% above its estimated fair value. The current 1-Year Sharpe Ratio is 1.30. Esprinet SpA's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Esprinet SpA (MIL:PRT), the current 1-Year Sharpe Ratio is 1.30 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Esprinet SpA (MIL:PRT) Overvalued in 2026?

Based on GuruFocus' analysis, Esprinet SpA stock appears to be overvalued. The current stock price of €7.03 is trading 21.2% above its estimated GF Value™ of €5.80. GuruFocus considers Esprinet SpA to be Modestly Overvalued.

Key valuation signals for MIL:PRT:

  • 1-Year Sharpe Ratio: 1.30
  • GF Value™: €5.80 vs. price of €7.03 (21.2% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the MIL:PRT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Esprinet SpA Business Description

Other Exchanges 0NFS:UKEP4A:Germany
Address Via Energy Park, 20, Vimercate, ITA, 20871
Esprinet SpA is engaged in the wholesale distribution of IT and consumer electronics in Italy and Spain. It's especially focused on delivering technology to resellers, mainly addressing the small-to-midsize businesses (SMB). The main activity is the wholesale distribution of IT products (hardware, software, and services) and consumer electronics, aimed at retailers oriented towards both consumer and business end-users. The company operates in Europe from Italy, Spain, Portugal, the Netherlands, and Ireland, and outside Europe, from Morocco, in the business-to-business (B2B) distribution of Information Technology (IT) and consumer electronics.
69GF Score

Get the complete analysis for MIL:PRT

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.03
Price
€5.80
GF Value